NYSE : DGX
Quest Diagnostics Incorporated — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 251.82 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 27.71B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 27.71B |
| Enterprise Value | 33.31B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 22, 2026 |
| Ex-Dividend Date | Oct 6, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 110.02M |
| Shares Outstanding | 110.02M |
| Shares Change (YoY) | -1.32% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 97.03% |
| Float | 109.43M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 25.09 |
| Forward PE | 21.71 |
| PS Ratio | 2.34 |
| Forward PS | 2.22 |
| PB Ratio | 3.63 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.15 |
| P/OCF Ratio | 14.20 |
| PEG Ratio | 2.31 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 29.60 |
| EV / Sales | 2.81 |
| EV / EBITDA | 14.16 |
| EV / EBIT | 18.85 |
| EV / FCF | 24.22 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.70 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 2.23 |
| Debt / FCF | 4.65 |
| Interest Coverage | 6.62 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 15.32% |
| Return on Assets (ROA) | 6.61% |
| Return on Invested Capital (ROIC) | 10.03% |
| Return on Capital Employed (ROCE) | 11.48% |
| Weighted Average Cost of Capital (WACC) | 6.47% |
| Revenue Per Employee | $207,737 |
| Profits Per Employee | $19,737 |
| Employee Count | 57,000 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 39.17 |
Taxes
| Measure | Value |
|---|
| Income Tax | 342.00M |
| Effective Tax Rate | 22.47% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +44.08% |
| 50-Day Moving Average | 238.54 |
| 200-Day Moving Average | 212.15 |
| Relative Strength Index (RSI) | 68.33 |
| Average Volume (20 Days) | 1,037,303 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.57M |
| Short Previous Month | 3.60M |
| Short % of Shares Out | 3.25% |
| Short % of Float | 3.27% |
| Short Ratio (days to cover) | 3.05 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 11.84B |
| Gross Profit | 3.93B |
| Operating Income | 1.77B |
| Pretax Income | 1.52B |
| Net Income | 1.13B |
| EBITDA | 2.35B |
| EBIT | 1.77B |
| Earnings Per Share (EPS) | $10.04 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 797.00M |
| Total Debt | 6.40B |
| Net Cash | -5.60B |
| Net Cash Per Share | -$50.90 |
| Equity (Book Value) | 8.03B |
| Book Value Per Share | 69.38 |
| Working Capital | 1.28B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.95B |
| Capital Expenditures | -576.00M |
| Depreciation & Amortization | 585.00M |
| Net Borrowing | -11.00M |
| Free Cash Flow | 1.38B |
| FCF Per Share | $12.50 |
Margins
| Measure | Value |
|---|
| Gross Margin | 33.18% |
| Operating Margin | 14.92% |
| Pretax Margin | 12.85% |
| Profit Margin | 9.53% |
| EBITDA Margin | 19.86% |
| EBIT Margin | 14.92% |
| FCF Margin | 11.61% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $3.44 |
| Dividend Yield | 1.37% |
| Dividend Growth (YoY) | 7.30% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 34.27% |
| FCF Payout Ratio | 27.52% |
| Buyback Yield | 1.32% |
| Shareholder Yield | 2.69% |
| Earnings Yield | 3.99% |
| FCF Yield | 4.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $257.27 |
| Price Target Difference | 2.16% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 6.00% |
| EPS Growth Forecast (3Y) | 9.69% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 21, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.43 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |